Study on the Role of CD~+CD28~-T Cells in Dissolving Endothelial Cells in the Patients with Acute Coronary Syndrome

Wenjun Sun

2010-01-01

Abstract:Objective We assay the number of CD+CD28-T cell in patients with acute coronary syndrome(ACS),activation state and ability of CD+CD28-T cell dissolving endothelial cell.Methods The number and the expression of CD161 on CD+CD28-T cells were determined with fluorescence-activated cell sorting.The cells were isolated with MACS,and the CD+CD28-T cells were cloned with cell cloning techniques.Human umbilical vein endothelial cells were incubated with CD+CD28-T cells,the ability of CD+CD28-T cells dissolving endothelial cells was determined with lactate dehydrogenase release method.Results numbers of the CD+CD28-T cells of the patients with ACS in peripheral blood were higher than the normal control group and SAP group.and the expression of CD161 on CD+CD28T cells was significantly higher than CD4+CD28+T-cells.The CD+CD28-T cell clones with stimulation of IL-12 expressed CD161,the CD+CD28-T cell clones without stimulation of IL-12 didn't express CD161.The ability of the CD+CD28-Tcells killing the endothelial cell was significantly higher than CD4+CD28+T-cell at different E/T ratios(5∶1 and 20∶1)(P0.05).Conclusion The number of the CD+CD28T cells of the patients with ACS in peripheral blood increase significantly and express CD161,and the cells is activated state,and have the ability of killing endothelial cells,and increased CD+CD28-T cells may affect the stability of coronary artery plaque.